International Review of Ophthalmology ›› 2024, Vol. 48 ›› Issue (3): 177-183.doi: 10.3760/ cma.j.issn.1673-5803.2024.03.004

Previous Articles     Next Articles

Research progress of stem cell exosomes in treatment of glaucoma

Lv Jiayan1, Fu Qiang2, Man Xuejing3   

  1. 1 Yantai Afflicated Hospital of Binzhou Medical University, Yantai 264000, Shandong, China; 2 College of Pharmacy, Binzhou Medical University, Yantai 264000, Shandong, China; 3 Yantai Yuhuangding Hospital, Yantai 264000, Shandong, China
  • Received:2024-02-01 Online:2024-06-22 Published:2024-06-17
  • Contact: Man Xuejing, Email:manxuejing@aliyun.com E-mail:manxuejing@aliyun.com
  • Supported by:
    Natural Science Foundation of Shandong Province(ZR2023MH262)

Abstract: Glaucoma is a group of diseases characterized by characteristic optic atrophy. Its pathological manifestations are the damage and apoptosis of retinal ganglion cells. Stem cell exosomes are extracellular microvesicles released by stem cells, which not only retain the function of stem cells in promoting the regeneration and repair of damaged retinal ganglion cells, but also mitigatethe side effects of stem cells, and therefore have become a substitute for stem cells. In addition, stem cell exosomes can also induce the proliferation of trabecular meshwork cells and promote aqueous humor outflow; and it can be used as a drug carrier of anti-scarring drug aptamer S58 in anti-glaucoma surgery, delaying the degradation of S58 and significantly enhancing the duration of its anti-scarring effect. Based on the biological characteristics and functions of exosomes. The research progress of exosomes in glaucoma treatment puts forward that exosomes secreted by stem cells have broad application prospects in glaucoma treatment.

Key words: glaucoma, stem cells, exosomes